Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease (Q62066961)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Anna Alisi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Andrea Pietrobattista

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Jean De Ville De Goyet

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Giorgio Bedogni

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

4

Rita De Vito

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

9

Massimo Pinzani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

6

Giuseppe Morino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Giuliano Torre

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

22 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

229-234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

Pediatric nonalcoholic fatty liver disease in 2009.

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Childhood NAFLD: a ticking time-bomb?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

The obesity epidemic and nonalcoholic fatty liver disease in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Advances in pediatric nonalcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Pediatric nonalcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Histopathology of non-alcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Non-invasive diagnosis of steatosis and fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Fibrosis in chronic liver diseases: diagnosis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Noninvasive diagnosis of fibrosis in chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Elevated serum ALT in children presenting to the emergency unit: Relationship with NAFLD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Blind and ultrasound-guided percutaneous liver biopsy in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Regression models for ordinal responses: a review of methods and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Paediatric non-alcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.05.008

10.1016/J.TRSL.2010.05.008

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20875899%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference